Existing Knowledge on Colorectal Cancer Colorectal cancer (CRC) is the third most common type of cancer and second most common cause of cancer-related deaths globally 1 . There were over 1.9 million new cases of CRC globally in 2020 with medium to h...
Chronic lymphocytic leukaemia (CLL) is a chronic lymphoproliferative disorder characterised by proliferation of monoclonal mature B-cells in peripheral blood, bone marrow, and secondary lymphoid tissues, such as spleen and lymph nodes 1 . The incide...
The management of relapsed and refractory multiple myeloma (RRMM) continues to be challenging though new therapeutics for the disease have been emerging in recent decades. Essentially, while decreased survival was observed in each extra line of ther...
Currently Available Therapeutic Options for MM MM is currently one of the most prevalent haematological malignancies, which mainly affects individuals aged above 65 2 , a relatively vulnerable group of patients owing to comorbidities and immunosenes...
The Multitude of Activities of IMiDs Because of the established benefits, IMiDs are recommended as induction therapy for both transplant eligible and ineligible patients, in the post-transplant maintenance setting, and for relapsed/refractory diseas...
Background Information The patient of the current case was a 64-year-old male with documented ischemic heart disease and received 3 times of percutaneous coronary intervention (PCI), respectively in 2004, 2005 and 2013. In 2015, the patient complain...
Where Are We in the Prevention of CRC? Ageing and male gender are common risk factors for CRC. In addition, a positive family history, a history of familial adenomatous polyposis, occurrence of Lynch syndrome, development of colonic polyp, and ulcer...
Exploring Chemotherapy-associated Cognitive Impairment in Colorectal Cancer Chemotherapy, which is commonplace in treating a plethora of cancers, has seen increasing concerns over its possible role in inducing cognitive impairment 1 . In breast canc...
Reduced Overall Survival in Refractory MM Although the application of the first IMiD, lenalidomide, had significantly increased median overall survival (OS) 2 , Prof. Leleu commented that the treatment success was hindered by the refractoriness of M...
Background of the Patient The patient was a 53-year-old female with good health record. In 2010, the patient presented with some bone pain and proteinuria (2.5 g/day). However, evaluation on albumin level did not indicate renal impairment. Dr. Hwang...
Therapeutic Sequencing Strategy in Multiple Myeloma Date: 24 th June 2021 (Thursday) Time: 19:00 - 20:40 (GMT+8, HKT) Meeting format: Zoom meeting Address: Salon Room III, Hyatt Regency Hong Kong, 18 Hanoi Road, Tsim Sha Tsui, Kowloon The survival o...
Breast cancer ranks the first place among female cancers in Hong Kong, with the incidence increased nearly 4 times within the past 25 years. Although a wide spectrum of therapies for breast cancer is currently available, the prognosis of the disease...
